Abstract

Antimicrobial peptides have been identified as one of the alternatives to the extensive use of common antibiotics as they show a broad spectrum of activity against human pathogens. Among these is Chionodracine (Cnd), a host-defense peptide isolated from the Antarctic icefish Chionodraco hamatus, which belongs to the family of Piscidins. Previously, we demonstrated that Cnd and its analogs display high antimicrobial activity against ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species). Herein, we investigate the interactions with lipid membranes of Cnd and two analogs, Cnd-m3 and Cnd-m3a, showing enhanced potency. Using a combination of Circular Dichroism, fluorescence spectroscopy, and all-atom Molecular Dynamics (MD) simulations, we determined the structural basis for the different activity among these peptides. We show that all peptides are predominantly unstructured in water and fold, preferentially as α-helices, in the presence of lipid vesicles of various compositions. Through a series of MD simulations of 400 ns time scale, we show the effect of mutations on the structure and lipid interactions of Cnd and its analogs. By explaining the structural basis for the activity of these analogs, our findings provide structural templates to design minimalistic peptides for therapeutics.

Highlights

  • Antimicrobial resistance towards widely used antibiotics has become a global health crisis [1]

  • The number of positive charges is critical for the activity of Antimicrobial peptides (AMP) due to the interaction with the negatively charged membranes of bacteria [32]

  • We evaluated the interactions of Cnd and its derived peptides with lipid bilayers formed by POPC and POPC/POPG LUVs using steady-state anisotropy (r) of DPH (1,6-Diphenyl-1,3,5-hexatriene)

Read more

Summary

Introduction

Antimicrobial resistance towards widely used antibiotics has become a global health crisis [1]. The diffusion of multidrug resistant (MDR) bacteria is widespread and infections caused by human pathogens often require multiple treatment, which not always effective. The search for new antimicrobial drugs to replace or integrate classical antibiotics is imperative. Many different alternatives have been proposed as potential drugs for the treatment of resistant bacterial strains such as antibodies, vaccines [3], bacteriophages [4,5], and antimicrobial peptides [6,7]. Antimicrobial peptides (AMP) represent the first line of innate immune system and are present in plants, microorganisms, and animals [8,9].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call